"As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion." Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Group's "GLP-1 & The Weight Loss Revolution Shopper Insights Study" was conducted Feb
Currently, we only ship compounded Semaglutide within the U.S
The application is based on a 64-week trial of 307 adults with obesity but without diabetes
The reality is that compounded semaglutide from licensed 503A compounding pharmacies continues to be a regulated and available treatment option, and PlexusDx provides access to this medication across all 50 states
Both have gained global attention for their ability to potentially aid substantial weight loss